Subcutaneous and intravenous ceftriaxone administration in patients more than 75years of age

Medecine et Maladies Infectieuses

Volumn 44, Issue 6, 2014, Pages 275-280

  Gauthier, D ^a   Schambach, S ^a   Crouzet, J ^a   Sirvain, S ^a   Fraisse, T ^a  

^a Service de court séjour gériatrique   (France)

Author keywords

Ceftriaxone; Geriatric patients; Subcutaneous administration

Indexed keywords

CEFTRIAXONE; ANTIINFECTIVE AGENT;

AGED; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FRAIL ELDERLY; GERIATRIC CARE; HEALTH STATUS; HUMAN; IMMOBILITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; VERY ELDERLY; BACTERIAL INFECTIONS; BLOOD COAGULATION DISORDERS; COMORBIDITY; HOSPITAL SUBDIVISIONS AND COMPONENTS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASES; MENTAL DISORDERS; SUBCUTANEOUS DRUG ADMINISTRATION;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD COAGULATION DISORDERS; CEFTRIAXONE; COMORBIDITY; DEMENTIA; FEMALE; FRAIL ELDERLY; HOSPITAL MORTALITY; HOSPITAL UNITS; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; KIDNEY DISEASES; MALE; MENTAL DISORDERS; RETROSPECTIVE STUDIES;

EID: 84902553611     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2014.03.007     Document Type: Article

References (24)

1. Lipschitz S., Campbell A.J., Roberts M.S., Wanwimolruk S., McQueen E.G., McQueen M., et al. Subcutaneous fluid administration in elderly subjects: validation of an under-used technique. J Am Geriatr Soc 1991, 39:6-9.
2. Dardaine V., Garrigue M.A., Rapin C.H., Constans T. Metabolic and hormonal changes induced by hypodermoclysis of glucose-saline solution in elderly patients. J Gerontol A Biol Sci Med Sci 1995, 50:334-336.
3. Roberts M.S., Lipschitz S., Campbell A.J., Wanwimolruk S., McQueen E.G., McQueen M. Modeling of subcutaneous absorption kinetics of infusion solutions in the elderly using technetium. J Pharmacokinet Biopharm 1997, 25:1-21.
4. Challiner Y.C., Jarrett D., Hayward M.J., al-Jubouri M.A., Julious S.A. A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgrad Med J 1994, 70:195-197.
5. Ferry M., Leverve X., Constans T. Comparison of subcutaneous and intravenous administration of a solution of amino acids in older patients. J Am Geriatr Soc 1997, 45:857-860.
6. Dardaine-Giraud V., Lamande M., Constans T. Hypodermoclysis: benefits and indications in geriatrics. Rev Med Interne 2005, 26:643-650.
7. Borner K., Lode H., Hampel B., Pfeuffer M., Koeppe P. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration. Chemotherapy 1985, 31:237-245.
8. Harb G., Lebel F., Battikha J., Thackara J.W. Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers. Curr Med Res Opin 2010, 26:279-288.
9. Bricaire F., Castaing J.L., Pocidalo J.J., Vilde J.L. Pharmacokinetics and tolerance of ceftriaxone after subcutaneous administration. Pathol Biol 1988, 36:702-705.
10. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
11. Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983, 31:721-727.
12. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47:1245-1251.
13. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
14. Comité technique des infections nosocomiales et des infections liées aux soins Définition des infections associées aux soins 2007.
15. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
16. Groupe transversal sepsis Prise en charge initiale des états septiques graves del'adulte et de l'enfant. Reanimation 2007, 16:S1-S21.
17. Robelet A., Caruba T., Corvol A., Begue D., Gisselbrecht M., Saint-Jean O., et al. Antibiotics given subcutaneously to elderly. Presse Med 2009, 38:366-376.
18. Rigaud D. Malnutrition. Clinical and biological signs, treatment. Rev Prat 1997, 47:999-1004.
19. Marcus EL, Clarfield AM, Moses AE. Ethical issues relating to the use of antimicrobial therapy in older adults. Clin Infect Dis 200;33:1697-705.
20. Fabiszewski K.J., Volicer B., Volicer L. Effect of antibiotic treatment on outcome of fevers in institutionalized Alzheimer patients. JAMA 1990, 263:3168-3172.
21. 15e conférence de consensus en thérapeutique anti-infectieuse Prise en charge des infections des voies respiratoires basses de l'adulte immunocomptent. Med Mal Infect 2006, 36:235-244.
22. Chidiac C. Antibiothérapie par voie générale dans les infections respiratoires basses de l'adulte. Pneumonie aiguë communautaire. Exacerbations de bronchopneumopathie chronique obstructive. Med Mal Infect 2001, 41:221-228.
23. Gupta K., Hooton T.M., Naber K.G., Wullt B., Colgan R., Miller L.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52:e103-e120.
24. Société française d'anesthésie et de reanimation Antibiothérapie probabiliste des états septiques graves. Ann Fr Anesth Reanim 2004, 23:1020-1026.